Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen
23:33 EDT 15 Aug 2012 | ChinaBio Today
Hainan Shuangcheng Pharmaceuticals debuted on the Shenzhen exchange last week, raising 600 million RMB ($94 million) in its IPO offering. Founded in 2000, Hainan Shuangcheng Pharma is a high-tech enterprise specializing in chemosynthetic polypepti..
Original Article: Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen
More From BioPortfolio on "Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
